AddLife AB (publ) (FRA:1AD1)

Market Cap	1.79B
Revenue (ttm)	952.18M
Net Income (ttm)	35.64M
Shares Out	n/a
EPS (ttm)	0.29
PE Ratio	50.18
Forward PE	25.72
Dividend	0.07 (0.44%)
Ex-Dividend Date	May 9, 2025

Volume	59
Average Volume	25
Open	14.53
Previous Close	15.66
Day's Range	14.53 - 14.55
52-Week Range	11.30 - 19.01
Beta	n/a
RSI	23.90
Earnings Date	Feb 4, 2026

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory analysis equipment. It offers products and solutions, including instruments and equipment, plastic consumables, cell biology, reagents, general ...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1906
• Employees: 2,181
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1AD1

Financial Performance

In 2024, AddLife AB's revenue was 10.29 billion, an increase of 6.21% compared to the previous year's 9.69 billion. Earnings were 252.00 million, an increase of 32.63%.

Financial numbers in SEK